Magnetophoresis in combination with chemical enhancers for transdermal drug delivery

Drug Development and Industrial Pharmacy

Volumn 37, Issue 9, 2011, Pages 1076-1082

  Sammeta, Srinivasa M ^a   Repka, Michael A ^a,b   Murthy, S Narasimha ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Chemical permeation enhancers; in vitro drug permeation; Lidocaine hydrochloride; Magnetophoresis; Transdermal patch system

Indexed keywords

DIMETHYL SULFOXIDE; DODECYL SULFATE SODIUM; HYDROXYPROPYLMETHYLCELLULOSE; LIDOCAINE; MENTHOL; PENETRATION ENHANCING AGENT; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG TRANSPORT; GEL; IN VITRO STUDY; MAGNET; MAGNETISM; MAGNETOPHORESIS; NONHUMAN; RAT; SKIN; TRANSDERMAL PATCH;

ANESTHETICS, LOCAL; ANIMALS; DRUG DELIVERY SYSTEMS; ELECTRIC IMPEDANCE; LIDOCAINE; MAGNETS; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SKIN ABSORPTION; TRANSDERMAL PATCH;

EID: 79961161684     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.559659     Document Type: Article

References (30)

1. Roberts MS, Cross SE. (1999). Percutaneous absorption of topically applied NSAIDS and other compounds: role of solute properties, skin physiology and delivery systems. Infammopharmacology, 7:339-350. (Pubitemid 30090298)
2. Cross SE, Roberts MS. (2004). Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? Curr Drug Deliv, 1:81-92.
3. Scheindlin S. (2004). Transdermal drug delivery: Past, Present, Future. Mol Interv, 4:308-312. (Pubitemid 40124375)
4. Prausnitz MR, Bose VG, Langer R, Weaver JC. (1993). Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA, 90:10504-10508. (Pubitemid 23347070)
5. Sintov AC, Krymberk I, Daniel D, Hannan T, Sohn Z, Levin G. (2003). Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J Control Release, 89:311-320. (Pubitemid 36507024)
6. Kalia YN, Naik A, Garrison J, Guy RH. (2004). Iontophoretic drug delivery. Adv Drug Deliv Rev, 56:619-658. (Pubitemid 38326937)
7. Prausnitz MR. (2004). Microneedles for transdermal drug delivery. Adv Drug Deliv Rev, 56:581-587. (Pubitemid 38326934)
8. Mitragotri S. (2005). Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov, 4:255-260. (Pubitemid 40372559)
9. Trommer H, Neubert RH. (2006). Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol, 19:106-121. (Pubitemid 43725821)
10. Oh SY, Jeong SY, Park TG, Lee JH. (1998). Enhanced transdermal delivery of AZT (Zidovudine) using iontophoresis and penetration enhancer. J Control Release, 51:161-168. (Pubitemid 28252867)
11. Ganga S, Ramarao P, Singh J. (1996). Efect of Azone on the iontophoretic transdermal delivery of metoprolol tartrate through human epidermis in vitro. Journal of Controlled Release, 42:57-64. (Pubitemid 26297876)
12. Mitragotri S, Ray D, Farrell J, Tang H, Yu B, Kost J et al. (2000). Synergistic efect of low-frequency ultrasound and sodium lauryl sulfate on transdermal transport. J Pharm Sci, 89:892-900.
13. Murthy SN, Sammeta SM, Bowers C. (2010). Magnetophoresis for enhancing transdermal drug delivery: Mechanistic studies and patch design. J Control Release, 148:197-203.
14. El Maghraby GM, Williams AC, Barry BW. (2001). Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. J Pharm Pharmacol, 53:1311-1322. (Pubitemid 32982247)
15. Essa EA, Bonner MC, Barry BW. (2002). Human skin sandwich for assessing shunt route penetration during passive and iontophoretic drug and liposome delivery. J Pharm Pharmacol, 54:1481-1490. (Pubitemid 35331210)
16. Sammeta SM, Vaka SR, Murthy SN. (2009). Dermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique. J Pharm Sci, 98:2677-2685.
17. Davies DJ, Ward RJ, Heylings JR. (2004). Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies. Toxicol in Vitro, 18:351-358. (Pubitemid 38376369)
18. Padula C, Colombo G, Nicoli S, Catellani PL, Massimo G, Santi P. (2003). Bioadhesive flm for the transdermal delivery of lidocaine: in vitro and in vivo behavior. J Control Release, 88:277-285. (Pubitemid 36287344)
19. Koizumi A, Fujii M, Kondoh M, Watanabe Y. (2004). Efect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur J Pharm Biopharm, 57:473-478. (Pubitemid 38490564)
20. Murthy SN, Vaka SR. (2009). Irontophoresis: transdermal delivery of iron by iontophoresis. J Pharm Sci, 98:2670-2676.
21. Oertel RP. (1977). Protein conformational changes induced in human stratum corneum by organic sulfoxides: an infrared spectroscopic investigation. Biopolymers, 16:2329-2345. (Pubitemid 8199484)
22. Anigbogu ANC, Williams AC, Barry BW, Edwards HGM. (1995). Fourier transform raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum. International Journal of Pharmaceutics, 125:265-282.
23. Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev, 56:603-618. (Pubitemid 38326936)
24. Chantasart D, Pongjanyakul T, Higuchi WI, Li SK. (2009). Efects of oxygen-containing terpenes as skin permeation enhancers on the lipoidal pathways of human epidermal membrane. J Pharm Sci, 98:3617-3632.
25. Williams AC, Barry BW. (1991). Te enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fuorouracil) drugs. International Journal of Pharmaceutics, 74:157-168.
26. Kunta JR, Goskonda VR, Brotherton HO, Khan MA, Reddy IK. (1997). Efect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J Pharm Sci, 86:1369-1373. (Pubitemid 28018316)
27. Jain AK, Tomas NS, Panchagnula R. (2002). Transdermal drug delivery of imipramine hydrochloride. I. Efect of terpenes. J Control Release, 79:93-101. (Pubitemid 34168193)
28. Benson HA. (2005). Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv, 2:23-33. (Pubitemid 40590918)
29. Yamashita F, Hashida M. (2003). Mechanistic and empirical modeling of skin permeation of drugs. Adv Drug Deliv Rev, 55:1185-1199. (Pubitemid 37087923)
30. Barry BW. (2002). Drug delivery routes in skin: a novel approach. Adv Drug Deliv Rev, 54 Suppl 1:S31-S40.